Suppr超能文献

印度 Rubinstein-Taybi 综合征患者中 CREBBP 突变的频谱。

Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome.

机构信息

National Centre for Cell Science, NCCS Complex, Pune University Complex, Ganeshkhind, Pune 411 007, India.

出版信息

J Biosci. 2010 Jun;35(2):187-202. doi: 10.1007/s12038-010-0023-5.

Abstract

Rubinstein-Taybi syndrome (RSTS), a developmental disorder comprising abnormalities that include mental retardation, an unusual facial appearance, broad thumbs and big toes is frequently associated with molecular lesions in the CREB-binding protein gene, CREBBP. The objective of the present study was to identify and analyse CREBBP mutations in Indian RSTS patients on which there are no data. Direct sequencing of CREBBP performed in 13 RSTS patients identified the three zinc fingers (CH1, CH2, CH3) and HAT domain as mutational hotspots in which ten novel pathogenic mutations were localized. Functional analysis revealed that three of these mutations affecting amino acids Glu1459, Leu1668 and Glu1724 were critical for histone acetyltransferase activity. Twenty-eight novel CREBBP single-nucleotide polymorphisms (SNPs) were also identified in the Indian population. Linkage disequilibrium studies revealed associations between (i) SNP (rs129974/c.3836-206G greater than C) and mutation (p.Asp1340Ala); (ii) (rs130002) with mutation (p.Asn435Lys) and (iii) SNPs rs129974, rs130002 and SNP (c.3836-206G greater than C) signifying a disease affection status. In conclusion, the present study reports the highest detection rate of CREBBP mutations (76.9%) in RSTS patients to date, of which ten are predicted to be pathogenic and three critical for histone acetyltransferase activity. Moreover, identification of the association of CREBBP polymorphisms with disease susceptibility could be an important risk factor for the pathogenesis of RSTS.

摘要

鲁宾斯坦-泰比综合征(RSTS)是一种发育障碍性疾病,其特征包括智力障碍、面部异常、宽拇指和大脚趾,常伴有 CREB 结合蛋白基因(CREBBP)的分子病变。本研究旨在确定并分析印度 RSTS 患者的 CREBBP 突变,因为目前尚无相关数据。对 13 例 RSTS 患者的 CREBBP 进行直接测序,发现锌指(CH1、CH2、CH3)和 HAT 结构域是突变热点,其中定位了 10 种新的致病性突变。功能分析显示,这三种突变影响到氨基酸 Glu1459、Leu1668 和 Glu1724,对组蛋白乙酰转移酶活性至关重要。还在印度人群中发现了 28 种新的 CREBBP 单核苷酸多态性(SNP)。连锁不平衡研究显示,(i)SNP(rs129974/c.3836-206G 大于 C)与突变(p.Asp1340Ala)之间存在关联;(ii)(rs130002)与突变(p.Asn435Lys)之间存在关联;(iii)SNP rs129974、rs130002 和 SNP(c.3836-206G 大于 C)表明疾病的发病状态。总之,本研究报告了迄今为止 RSTS 患者中 CREBBP 突变的最高检出率(76.9%),其中 10 种突变被预测为致病性突变,3 种突变对组蛋白乙酰转移酶活性至关重要。此外,CREBBP 多态性与疾病易感性的关联可能是 RSTS 发病机制的一个重要危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验